BCBA/TMOD (BCBA/TMOD)

Buenos Aires Stock Exchange: BCBA/TMOD · USD

$33.0

-1.05 (-3.1%)· Recorded snapshot

Market cap	393.6T
Revenue (ttm)	72.1T
Net income (ttm)	10.8T
EPS (ttm)	$1,388
P/E (trailing)	36.5x
P/E (forward)	25.7x
Dividend	$81.7 (0.16%)
Volume	59

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 72.1T
Net income (ttm): 10.8T
EPS (ttm): $1,388
P/E (trailing): 36.5x
P/E (forward): 25.7x
Market cap: 393.6T

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E25.7

P25 n/aP50 n/aP75 n/a

Trailing P/E36.5

P25 n/aP50 n/aP75 n/a

ROE13.4

P25 n/aP50 n/aP75 n/a

ROIC9.1

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

S&P 500+0.8%

Nasdaq Composite-1.0%

Dow Jones Industrial Average+1.9%

Russell 2000+0.3%

All BCBA/TMOD indicators

Market & fundamental data

Available fields

230

Groups with data

Currency

USD

Showing 230 of 230 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	ARS
Country	United States
Country code	AR
Earnings date	2026-10-21
Employees	125,000
Employees change	0
Employees growth	0%
Enterprise value	$448.1T
Exchange	Buenos Aires Stock Exchange
Financial currency	USD
Financial report date	2026-09-26
First seen	2026-09-01
Fiscal year end	December
Founded	1956
Industry	Diagnostics & Research
Is primary listing	No
ISIN number	ARBCOM4601F7
Last earnings date	2026-10-21
Last refreshed	2026-10-28
Market cap	$393.6T
Price	$32.97
Price currency	USD
Sector	Healthcare
SIC code	3826
Stock price date	2026-10-26
Symbol	bcba/TMOD
Website	https://www.thermofisher.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	31.57x
Average P/E ratio (3Y)	31.2x
Average P/E ratio (5Y)	31.63x
Earnings yield	2.74%
EV/Earnings	41.64x
EV/EBIT	32.31x
EV/EBITDA	23.09x
EV/FCF	38.77x
EV/Sales	6.16x
FCF / EV yield	2.58%
FCF yield	2.94%
Forward P/E	25.73x
Graham number	11.91041
Graham upside	-63.88%
Lynch fair value	$4.51
Lynch upside	-86.33%
P/(FCF - SBC) ratio	35.51x
P/(OCF - SBC) ratio	28.7x
P/B ratio	4.71x
P/E ratio	36.54x
P/FCF ratio	34.06x
P/OCF ratio	27.75x
P/S ratio	5.46x
Price/EBITDA ratio	21.21x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	19.2%
EBITDA margin	25.76%
Effective tax rate	9.48%
FCF margin	15.89%
Gross margin	41.18%
Operating margin	19.2%
Pretax margin	16.55%
Profit margin	14.94%
Profit per employee	$86.2M
Profitable quarters	98
Profitable years	24
Revenue per employee	$577.1M
ROA	5.23%
ROA (5Y)	5.62%
ROCE	9.09%
ROE	13.38%
ROE (5Y)	15.21%
ROIC	9.07%
ROIC (5Y)	10.84%
SBC / revenue	0.65%
Tax / revenue	1.57%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	9.54%
EPS growth (Q)	8.67%
EPS growth (QoQ)	-0.84%
EPS growth 10Y	14.26%
EPS growth 3Y	7.53%
EPS growth 5Y	-2.52%
EPS growth quarters	7
EPS growth years	2
FCF growth	24.3%
FCF growth (Q)	15.15%
FCF growth (QoQ)	26.15%
FCF growth 3Y	5.08%
FCF growth 5Y	-0.82%
Gross profit growth	7.71%
Gross profit growth (Q)	13.24%
Gross profit growth 3Y	3.89%
Gross profit growth 5Y	-0.46%
Net income growth	7.64%
Net income growth (Q)	6.5%
Net income growth (QoQ)	-0.86%
Net income growth 3Y	5.98%
Net income growth 5Y	-3.76%
Net income growth quarters	3
Net income growth years	2
OCF growth	21.87%
OCF growth (Q)	13.89%
OCF growth (QoQ)	20%
OCF growth 10Y	11.01%
OCF growth 3Y	4.5%
OCF growth 5Y	-1.77%
Operating income growth	11.07%
Operating income growth (Q)	14.32%
Operating income growth 3Y	6.53%
Operating income growth 5Y	-3.21%
Revenue growth	8.27%
Revenue growth (Q)	9.13%
Revenue growth (QoQ)	1.19%
Revenue growth 10Y	10.17%
Revenue growth 3Y	2.93%
Revenue growth 5Y	3.93%
Revenue growth quarters	8
Revenue growth years	2

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-2.6T
Depreciation and amortization	$4.8T
EBIT	$13.9T
EBITDA	$18.6T
EPS	$1,388.07
Financing cash flow	$3T
Free cash flow	$11.6T
Free cash flow minus SBC	$11.1T
Gross profit	$29.7T
Income taxes	$1.1T
Investing cash flow	$-12.2T
Net borrowing	$9.8T
Net cash flow	$5.3T
Net income	$10.8T
Operating cash flow minus SBC	$13.7T
Operating income	$13.9T
Revenue	$72.1T
Stock-based compensation	$472.3B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	$225,506.82
Debt / EBITDA	3.26
Debt / equity	0.75
Debt / FCF	5.45
Goodwill	$83.5T
Interest coverage	5.92
Long-term assets	$134.6T
Long-term liabilities	$68.6T
Net cash (debt)	$-53.8T
Net cash / market cap	-13.65%
Net debt / EBITDA	2.89
Net debt / equity	0.64
Net debt / FCF	4.65
Piotroski F-Score	6
Property, plant and equipment	$16.3T
Shareholders' equity	$83.6T
Tangible book value	$-26.8T
Tangible book value per share	$-72,358.01
Total assets	$174T
Total cash	$9.2T
Total debt	$63T
Total liabilities	$90.4T

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.44
Current assets	$39.4T
Current liabilities	$21.8T
Current ratio	1.81
Inventory turnover	4.89
Net working capital	$11.6T
Quick ratio	1.11
Working capital	$17.4T
Working capital turnover	7,653.22

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	1.52%
Dividend growth	9.53%
Dividend growth (3Y)	10.88%
Dividend growth years	4
Dividend payment date	2026-10-15
Dividend payment years	6
Dividend payout frequency	Quarterly
Dividend per share	$81.75
Dividend yield	0.16%
Ex-dividend date	2026-09-15
Last dividend	$0.01
Payout ratio	9.52%
Shareholder yield	1.68%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$26.13
1D price change	-3.09%
1M price change	4.27%
1M total return	4.27%
1W price change	-0.99%
1W total return	-0.99%
1Y price change	31.88%
1Y return CAGR	32.23%
1Y total return	32.2%
20-day SMA	$31.76
3M price change	22.75%
3M total return	22.84%
50-day SMA	$29.18
52-week high	$34.02
52-week high date	2026-10-21
52-week low	$20.80
52-week low date	2026-05-15
6M price change	46.47%
6M total return	46.67%
All-time high	$34.02
All-time high date	2026-10-21
All-time low	$18.00
All-time low date	2025-06-17
Average true range (ATR)	$0.61
Average volume	34.1
Change from 52-week high	-3.09%
Change from 52-week low	58.51%
Change from all-time high	-3.09%
Change from all-time low	83.17%
Change from open	0%
Day's gap	-3.09%
Dollar volume	$1,945
High price	$32.97
Low price	$32.97
Monthly RSI	59.06
Open price	$32.97
Previous close	$34.02
Price vs 150-day SMA	26.16%
Price vs 20-day SMA	3.8%
Price vs 50-day SMA	12.99%
Relative volume	1.73
RSI	62.78
Sharpe ratio	0.72
Sortino ratio	0.98
Volume	59
Weekly RSI	65.28
YTD price change	18.9%
YTD total return	19.13%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	368.8M
Shares change (QoQ)	0%
Shares change (YoY)	-1.52%
Shares held by insiders	0.12%
Shares held by institutions	92.52%
Short ratio	2.3 days

Deeper analysis on BCBA/TMOD

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Scorecard

Six-factor overlay and 9-category weighted scorecard.

→

Recommendation

Final action, action steps, opportunity, and biggest risk.

→

Perspectives

Growth, value, and income investor reads.

→

Frequently asked questions

About this BCBA/TMOD report

Is a complete BCBA/TMOD research report available?

No complete published report is available for bcba/TMOD (BCBA/TMOD) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Market cap

393.6T

Revenue (ttm)

72.1T

Net income (ttm)

10.8T

EPS (ttm)

$1,388

P/E (trailing)

36.5x

P/E (forward)

25.7x

Dividend

$81.7 (0.16%)

Volume

Metric

Value

Amount currency

ARS

Country

United States

Country code

Earnings date

2026-10-21

Employees

125,000

Employees change

Employees growth

Enterprise value

$448.1T

Exchange

Buenos Aires Stock Exchange

Financial currency

USD

Financial report date

2026-09-26

First seen

2026-09-01

Fiscal year end

December

Founded

1956

Industry

Diagnostics & Research

Is primary listing

ISIN number

ARBCOM4601F7

Last earnings date

2026-10-21

Last refreshed

2026-10-28

Market cap

$393.6T

Price

$32.97

Price currency

USD

Sector

Healthcare

SIC code

3826

Stock price date

2026-10-26

Symbol

bcba/TMOD

Website

https://www.thermofisher.com

Metric

Value

Average P/E ratio (10Y)

31.57x

Average P/E ratio (3Y)

31.2x

Average P/E ratio (5Y)

31.63x

Earnings yield

2.74%

EV/Earnings

41.64x

EV/EBIT

32.31x

EV/EBITDA

23.09x

EV/FCF

38.77x

EV/Sales

6.16x

FCF / EV yield

2.58%

FCF yield

2.94%

Forward P/E

25.73x

Graham number

11.91041

Graham upside

-63.88%

Lynch fair value

$4.51

Lynch upside

-86.33%

P/(FCF - SBC) ratio

35.51x

P/(OCF - SBC) ratio

28.7x

P/B ratio

4.71x

P/E ratio

36.54x

P/FCF ratio

34.06x

P/OCF ratio

27.75x

P/S ratio

5.46x

Price/EBITDA ratio

21.21x

Metric

Value

EBIT margin

19.2%

EBITDA margin

25.76%

Effective tax rate

9.48%

FCF margin

15.89%

Gross margin

41.18%

Operating margin

19.2%

Pretax margin

16.55%

Profit margin

14.94%

Profit per employee

$86.2M

Profitable quarters

Profitable years

Revenue per employee

$577.1M

ROA

5.23%

ROA (5Y)

5.62%

ROCE

9.09%

ROE

13.38%

ROE (5Y)

15.21%

ROIC

9.07%

ROIC (5Y)

10.84%

SBC / revenue

0.65%

Tax / revenue

1.57%

Metric

Value

EPS growth

9.54%

EPS growth (Q)

8.67%

EPS growth (QoQ)

-0.84%

EPS growth 10Y

14.26%

EPS growth 3Y

7.53%

EPS growth 5Y

-2.52%

EPS growth quarters

EPS growth years

FCF growth

24.3%

FCF growth (Q)

15.15%

FCF growth (QoQ)

26.15%

FCF growth 3Y

5.08%

FCF growth 5Y

-0.82%

Gross profit growth

7.71%

Gross profit growth (Q)

13.24%

Gross profit growth 3Y

3.89%

Gross profit growth 5Y

-0.46%

Net income growth

7.64%

Net income growth (Q)

6.5%

Net income growth (QoQ)

-0.86%

Net income growth 3Y

5.98%

Net income growth 5Y

-3.76%

Net income growth quarters

Net income growth years

OCF growth

21.87%

OCF growth (Q)

13.89%

OCF growth (QoQ)

20%

OCF growth 10Y

11.01%

OCF growth 3Y

4.5%

OCF growth 5Y

-1.77%

Operating income growth

11.07%

Operating income growth (Q)

14.32%

Operating income growth 3Y

6.53%

Operating income growth 5Y

-3.21%

Revenue growth

8.27%

Revenue growth (Q)

9.13%

Revenue growth (QoQ)

1.19%

Revenue growth 10Y

10.17%

Revenue growth 3Y

2.93%

Revenue growth 5Y

3.93%

Revenue growth quarters

Revenue growth years

Metric

Value

Capital expenditures

$-2.6T

Depreciation and amortization

$4.8T

EBIT

$13.9T

EBITDA

$18.6T

EPS

$1,388.07

Financing cash flow

$3T

Free cash flow

$11.6T

Free cash flow minus SBC

$11.1T

Gross profit

$29.7T

Income taxes

$1.1T

Investing cash flow

$-12.2T

Net borrowing

$9.8T

Net cash flow

$5.3T

Net income

$10.8T

Operating cash flow minus SBC

$13.7T

Operating income

$13.9T

Revenue

$72.1T

Stock-based compensation

$472.3B

Metric

Value

Book value per share

$225,506.82

Debt / EBITDA

3.26

Debt / equity

0.75

Debt / FCF

5.45

Goodwill

$83.5T

Interest coverage

5.92

Long-term assets

$134.6T

Long-term liabilities

$68.6T

Net cash (debt)

$-53.8T

Net cash / market cap

-13.65%

Net debt / EBITDA

2.89

Net debt / equity

0.64

Net debt / FCF

4.65

Piotroski F-Score

Property, plant and equipment

$16.3T

Shareholders' equity

$83.6T

Tangible book value

$-26.8T

Tangible book value per share

$-72,358.01

Total assets

$174T

Total cash

$9.2T

Total debt

$63T

Total liabilities

$90.4T

Metric

Value

Asset turnover

0.44

Current assets

$39.4T

Current liabilities

$21.8T

Current ratio

1.81

Inventory turnover

4.89

Net working capital

$11.6T

Quick ratio

1.11

Working capital

$17.4T

Working capital turnover

7,653.22

Metric

Value

Buyback yield / dilution

1.52%

Dividend growth

9.53%

Dividend growth (3Y)

10.88%

Dividend growth years

Dividend payment date

2026-10-15

Dividend payment years

Dividend payout frequency

Quarterly

Dividend per share

$81.75

Dividend yield

0.16%

Ex-dividend date

2026-09-15

Last dividend

$0.01

Payout ratio

9.52%

Shareholder yield

1.68%

Metric

Value

150-day SMA

$26.13

1D price change

-3.09%

1M price change

4.27%

1M total return

4.27%

1W price change

-0.99%

1W total return

-0.99%

1Y price change

31.88%

1Y return CAGR

32.23%

1Y total return

32.2%

20-day SMA

$31.76

3M price change

22.75%

3M total return

22.84%

50-day SMA

$29.18

52-week high

$34.02

52-week high date

2026-10-21

52-week low

$20.80

52-week low date

2026-05-15

6M price change

46.47%

6M total return

46.67%

All-time high

$34.02

All-time high date

2026-10-21

All-time low

$18.00

All-time low date

2025-06-17

Average true range (ATR)

$0.61

Average volume

34.1

Change from 52-week high

-3.09%

Change from 52-week low

58.51%

Change from all-time high

-3.09%

Change from all-time low

83.17%

Change from open

Day's gap

-3.09%

Dollar volume

$1,945

High price

$32.97

Low price

$32.97

Monthly RSI

59.06

Open price

$32.97

Previous close

$34.02

Price vs 150-day SMA

26.16%

Price vs 20-day SMA

3.8%

Price vs 50-day SMA

12.99%

Relative volume

1.73

RSI

62.78

Sharpe ratio

0.72

Sortino ratio

0.98

Volume

Weekly RSI

65.28

YTD price change

18.9%

YTD total return

19.13%

Metric

Value

Float

368.8M

Shares change (QoQ)

Shares change (YoY)

-1.52%

Shares held by insiders

0.12%

Shares held by institutions

92.52%

Short ratio

2.3 days

BCBA/TMOD (BCBA/TMOD)

Price

Financial snapshot

Fair-value bridge

Latest news · BCBA/TMOD

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BCBA/TMOD indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BCBA/TMOD

Frequently asked questions

BCBA/TMOD (BCBA/TMOD)

Price

Financial snapshot

Fair-value bridge

Latest news · BCBA/TMOD

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BCBA/TMOD indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BCBA/TMOD

Frequently asked questions